Explore more topics
SEC Form 4 research

ACADIA PHARMACEUTICALS INC insider transactions

Inspect ACADIA PHARMACEUTICALS INC's public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001070494
Reporting owners
47
Officers and directors
25
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-08-082026-08-06Schneyer Mark C.S9,292$29.34Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-08-06 and its public availability date is 2026-08-08. Subtracting those calendar dates gives 2 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code S: a sale. A purchase-following rule excludes this sale even if the reported dollar amount is large.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 5 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-08-082026-08-06Schneyer Mark C.S9,292$29.34Not reported
2026-08-082026-08-06Schneyer Mark C.S5,000$29Not reported
2026-08-082026-08-05Schneyer Mark C.S5,849$29Not reported
2026-08-012026-07-30Thompson Elizabeth H.Z.S50$26.17Not reported
2026-08-012026-07-30Thompson Elizabeth H.Z.S16,508$26.13Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 37 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

Daly James M000156078247
Brege Laura000136561965
Kihara James000181616029
Teehan Brendan000189190016
HARRIGAN EDMUND00011779175
Schneyer Mark C.000189997731
SOLAND DANIEL B000131848516
DAVIS STEPHEN000113114646
Ridloff Elena000177251823
Thompson Elizabeth H.Z.00018614779
14159, L.P.00015511381,049
667, L.P.00015511392,118
Aasen Thomas H000129196925
Baity Glenn000148710028
Baker Bros. Advisors (GP) LLC00015805752,197
BAKER BROS. ADVISORS LP00012635082,370
Baker Brothers Life Sciences LP00013633642,127
BAKER FELIX00010879404,174
BAKER JULIAN00010879394,416
BORER MICHAEL T00010713432
Brann Mark R000129196810
GAROFALO ELIZABETH A.00018263613
GRAY MARY ANN00012619748
Hacksell Uli000129196248
Iversen Leslie L00012916235
KAPLAN LESTER J PH D00010163643
KIM AUSTIN D.000174624015
Lundstrom Brian000130984916
Miller Eric Alejandro00017584943
Mills Roger00013681903
Moore Terrence O00014542764
Owen Adams Catherine00018168381
Rasmussen Torsten00012918816
Rhodes Jennifer J000156824932
Stankovic Srdjan R.000143254523
Wells William McDowall00014768608
YANG MICHAEL J.000170228311

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.